Semaglutide is the active ingredient in Ozempic and Wegovy. It's used for weight loss and diabetes management.
New research suggests a link between semaglutide and NAION, a rare eye condition that can cause blindness.
People with diabetes and obesity who take semaglutide might be at higher risk for NAION.
NAION can cause sudden vision loss in one eye. There's often no pain.
If you're taking Ozempic or Wegovy and experience vision changes, see your doctor immediately.
While the risk is low, it's important to weigh the benefits and risks of semaglutide with your doctor.
Scientists are still studying the link between semaglutide and NAION. More research is needed.